CD79A and plasma cell myeloma: Compared to other IgA myeloma patients, myeloma patients with EBNA-1-specific IgA were relatively young at the time of diagnosis (≤63 years old), as reported for myeloma patients with EBNA-1-specific monoclonal IgG (12).